Skip to content
BritonOne Technology
Industries / Pharma

Pharma engineering that clears FDA

Clinical platforms, pharmacovigilance, eCTD submissions, and discovery AI, shipped by senior teams from inside Tier-1 pharma, CDMOs, and CROs.

0+Pharma & CRO programmes
0%First-pass FDA / EMA inspection
0%Faster study start-up
Pharma: glossy capsule and molecular-data motif representing clinical, regulatory, and discovery engineering
What we deliver

The whole pharma stack, one pod

Build, validate, and run the full pharma estate under a single accountable senior pod.

Clinical trial analytics dashboards showing patient enrolment, study metrics, and real-time trial data across multiple screens

Clinical Trials & eTMF

Trial platforms (eTMF, IRT/IWRS, site management) on Veeva Vault or bespoke, validated end to end.

Clinician capturing electronic patient data on a tablet at a desk, with a clinical dashboard on the monitor behind

EDC & Patient Capture

ePRO and eCOA capture wired into Medidata Rave, Oracle Clinical, and OpenClinica, GCP-validated, audit-trailed.

Lab technician scanning a product barcode into a safety database, with product profile and analytics dashboards on screen

Pharmacovigilance & Safety

ICSR intake, signal detection, and aggregate reporting, Argus and ArisGlobal, aligned to E2B(R3) and MedDRA.

REGULYS eCTD submissions platform headed 'Streamlined eCTD Submissions & Global Compliance', with global-submissions, deadline-tracker, and approvals tiles and a workflow board.

eCTD Submissions

Auto-publishing eCTD platforms with FDA/EMA gateway integration, IND, NDA, MAA, and BLA, lifecycle-managed.

GxP Data & Lineage platform headed 'GxP Data & Lineage', with a data-lineage flow, pipeline-health and data-quality gauges, and a traceability chain from raw data to CSR figure.

GxP Data & Lineage

Validated lakes, SDTM/ADaM pipelines, and full lineage, every CSR figure traceable to source.

Translucent drug capsules with a silver molecular structure model emerging from one, generative chemistry and molecular design

AI for Drug Discovery

Target ID, generative chemistry, ADMET prediction, and trial AI, with eval harnesses and model-risk packs.

The pharma advantage

Trials Started Faster. Submissions Cleared Sooner.

Every BritonOne Technology pharma programme ships its validation pack, audit trail, and 21 CFR Part 11 evidence alongside the code, not three months after the inspection. The result: 42% faster study start-up, zero FDA Form 483 observations on engineered systems, and submissions that clear EMA on first read.

BritonOne Technology
Before: Traditional Pharma IT
  • Validation packs assembled at inspection

    IQ/OQ/PQ scrambled the month before audit, and findings repeat at every inspection cycle.

  • Trial start-up takes months

    Bespoke site builds, paper-heavy training, and manual CRF programming bottleneck every study.

  • SDTM mapping by hand

    Statisticians map raw CRF data to SDTM weeks before lock; errors surface in the CSR review.

  • Pharmacovigilance backlogs

    ICSRs queue for manual coding; aggregate reports miss windows; agencies escalate.

BritonOne Technology
Now: BritonOne Technology-Engineered Pharma
  • 21 CFR Part 11 baked in from day one

    Audit trails, electronic signatures, and validation evidence emit per release, every build is inspection-ready.

  • Sites stood up in days

    Templated study builds, automated CRF generation, and pre-validated components compress start-up.

  • Auto-SDTM and define.xml

    Mappings live as code, gated in CI, regenerated on every CRF change, lock cycles drop by weeks.

  • Real-time PV with auto-coding

    MedDRA auto-coding, signal detection in-pipeline, and aggregate reports generated on demand.

Faster study start-up
42%Lock cycle compressed
100%First-pass agency review
0Form 483 observations
Faster study start-up
42%Lock cycle compressed
100%First-pass agency review
0Form 483 observations

Where pharma customers see it pay off

Selected programmes across Tier-1 pharma, speciality, CDMOs, CROs, and emerging biotech, anonymised where required, specific on the outcome.

Tier-1 Pharma52% drafting time saved

Generative AI for medical writing at a top-5 pharma

Production RAG over clinical study reports, regulatory submissions, and target labels, 4,200 medical writers and regulatory affairs colleagues live on the platform. Validation pack and 21 CFR Part 11 audit trail shipped alongside the build; cleared model risk on first review. Document drafting time cut by half across CSR, IB, and protocol templates.

  • GenAI medical writing
  • Veeva + Azure
  • 21 CFR Part 11
Generative AI for medical writing at a top-5 pharma
Speciality Pharma0 late submissions

Pharmacovigilance modernisation

ICSR intake, MedDRA auto-coding, and signal detection rebuilt, agency windows met without overtime.

  • Argus + signal detection
  • MedDRA auto-coding
  • ICSR pipeline
Pharmacovigilance modernisation
CRO3 wks to first patient

EDC platform for a global CRO

Templated study builds with auto-CRF generation, site activation in days, not months.

  • Medidata Rave
  • Auto-CRF generation
  • Templated studies
EDC platform for a global CRO
CDMO98% right-first-time

MES + LIMS integration at a contract manufacturer

Bidirectional MES/LIMS wiring with batch-record automation, GMP audit trail captured at every step.

  • MES + LIMS bridge
  • GMP batch records
  • Right-first-time
MES + LIMS integration at a contract manufacturer
Patient Support+27% adherence

Patient support programme for a rare-disease pharma

HIPAA + GDPR-grade patient portal with adherence tracking and HCP messaging.

  • Patient portal
  • HIPAA + GDPR
  • HCP messaging
Patient support programme for a rare-disease pharma
Emerging Biopharma1 quarter to ready

End-to-end clinical platform for a Phase III biopharma

EDC, eCRF, ePRO, eConsent, and randomisation on one validated platform, with medical coding to WHODrug and MedDRA and an audit trail per subject, stood up in a single quarter for a Phase III programme.

  • EDC + eConsent
  • WHODrug / MedDRA coding
  • Phase III ready
End-to-end clinical platform for a Phase III biopharma
Platform expertise

Platforms we integrate against

Production integrations across every major pharma estate: clinical, regulatory, safety, and quality on one GxP-clean surface.

Connected. Unified. Audit-ready.

  • Veeva Vault
  • Medidata Rave
  • Oracle Clinical / Argus
  • IQVIA · ArisGlobal

21 CFR Part 11 baked in

Audit trails, e-signatures, and CSV evidence emit per release, every build is inspection-ready, not retrofitted.

SDTM and define.xml as code

Mappings live in the repo, gated in CI, regenerated on every CRF change, no late-stage scramble to lock before the CSR.

Validation pack ships with the build

IQ/OQ/PQ, traceability matrices, and risk assessments emit per release, QA reviews evidence that already exists.

Our engagement workflow

Seven stages from first call to ongoing support

Every engagement walks the same path, sized to your problem, but with the same verification gates baked in.

  • Phase 01

    Discovery

    Two-week paid sprint. Architect-led. Output: regulator map, costed roadmap, signed scope.

  • Phase 02

    Planning

    Pod composition, sequenced milestones, change-control governance, and risk register.

  • Phase 03

    Design

    Reference architecture, threat model, design system, and acceptance criteria locked.

  • Phase 04

    Development

    Weekly demos, trunk-based, CI/CD from day one. Code reviewed against spec at every gate.

  • Phase 05

    Testing

    Unit, integration, e2e, security, performance, and accessibility, automated and gated.

  • Phase 06

    Deployment

    Blue-green or canary, observability live before launch, rollback rehearsed.

  • Phase 07

    Support

    Managed services or hypercare hand-off. Defined SLOs, named on-call, monthly reviews.

Success stories

Programmes we have shipped

AI governance and model-risk framework for a pharma company
9 weeks
Pharma

AI governance and model-risk framework for a pharma company

Stood up a board-ready AI governance and model-risk framework for a pharma company in 9 weeks, cleared at first internal audit.

GovernanceModel riskGxPEU AI Act
Country · CH
Legacy modernisation for a pharma manufacturer
40%
Pharma

Legacy modernisation for a pharma manufacturer

Strangled a validated legacy system into microservices, cutting change lead time 40% for a pharma manufacturer.

JavaSpringKafkaOpenShiftOracle
Country · CH
GxP-compliant CI/CD for a pharma manufacturer
8x
Pharma

GxP-compliant CI/CD for a pharma manufacturer

Delivered validated, GxP-compliant CI/CD, cutting release lead time 8x with full audit evidence.

GitLab CITerraformKubernetesAnsible
Country · CH
Data governance and catalogue for a pharma manufacturer
100%
Pharma

Data governance and catalogue for a pharma manufacturer

Catalogued and lineage-traced 100% of GxP-regulated data domains for a pharma manufacturer.

CollibradbtSnowflakeOpenLineage
Country · CH
GxP and Annex 11 compliance for a pharma manufacturer
12 weeks
Pharma

GxP and Annex 11 compliance for a pharma manufacturer

Reached validated Annex 11 compliance for a pharma manufacturer in 12 weeks.

GovernanceGAMP 5Annex 11Vanta
Country · CH
Agentic procurement triage for an NHS trust
73%
Healthcare

Agentic procurement triage for an NHS trust

Routed and matched 73% of purchase requests end to end, escalating only genuine exceptions.

PythonLangGraphAzureSQL Server
Country · UK
Symptom-check and triage app for a telemedicine provider
54%
Telemedicine

Symptom-check and triage app for a telemedicine provider

Photo-and-symptom-first triage app cut consultation prep time 54% for a telemedicine provider.

React NativeTypeScriptAzure
Country · UK
Datacenter exit for an NHS hospital group
900
Healthcare

Datacenter exit for an NHS hospital group

Migrated 900 clinical workloads off two datacentres to the cloud with zero downtime on patient-facing systems.

AzureTerraformAzure MigrateAnsible
Country · UK
24/7 SRE for a telemedicine platform
99.98%
Telemedicine

24/7 SRE for a telemedicine platform

Ran a telemedicine platform to a 99.98% SLO with a follow-the-sun on-call.

KubernetesPrometheusPagerDutyTerraform
Country · UK
Managed FinOps for a biotech scale-up
37%
Biotech

Managed FinOps for a biotech scale-up

Cut monthly cloud spend 37% for a genomics biotech without slowing a single pipeline.

AWSKubecostTerraformAWS Batch
Country · UK
Claims and billing analytics for a hospital group
38%
Healthcare

Claims and billing analytics for a hospital group

Unified claims and billing data, cutting rejected-claim rework 38% for a hospital group.

SnowflakedbtFHIRPower BI
Country · UK
Patient 360 for a telemedicine provider
24%
Telemedicine

Patient 360 for a telemedicine provider

Unified a fragmented patient view, lifting care-team efficiency 24% at a telemedicine provider.

SnowflakedbtPower BIFHIR
Country · UK
Penetration test for a hospital estate
61
Healthcare

Penetration test for a hospital estate

Surfaced 61 exploitable paths across a hospital estate, prioritised by patient-safety impact.

ProwlerScoutSuiteCobalt StrikeNessus
Country · UK
ISO 27001 and DTAC for a telemedicine platform
first pass
Telemedicine

ISO 27001 and DTAC for a telemedicine platform

Achieved ISO 27001 and NHS DTAC assurance at first assessment for a telemedicine platform.

ISO 27001NHS DTACVantaGovernance
Country · UK
Threat modelling a biotech lab-data platform
9
Biotech

Threat modelling a biotech lab-data platform

Identified nine design-level risks in a biotech's lab-data platform before build.

STRIDEAttack treesThreat modelling
Country · UK
Penetration and data-protection testing for a credential vault
Encryption verified
Healthcare

Penetration and data-protection testing for a credential vault

Penetration-tested the credential vault and its sync, verifying encryption and access controls end to end so stored secrets stayed protected.

Burp SuiteCryptographySASTDAST
Country · US
Health-data integrity and consent architecture advisory
Audit-ready design
Healthcare

Health-data integrity and consent architecture advisory

Delivered an audit-ready blockchain architecture for tamper-evident patient records and consent, cleared against HIPAA and GDPR before build.

Solution architectureSecurity advisoryConsent / DIDCompliance
Country · SG

Who we are

About us

BritonOne Technology is a full-cycle engineering company that builds and operates production software for regulated estates. Since 2017, we have shipped programmes that clear audit on the first pass across banking, insurance, wealth, healthcare, and biotech. Our teams pair deep domain knowledge with disciplined engineering, treating compliance, security, and resilience as first-class deliverables. From architecture through to live operations, we stay accountable for the systems we build, measuring success by uptime, audit outcomes, and defensible business results.

60+Senior engineers across UK and EU

Why choose us

Engineer experience, average9+ yrs
Specialist replacement window48h
Code and IP ownership, day one100%
Surprise invoicesZero
Why teams choose BritonOne Technology

Four reasons enterprise buyers come back

We don't compete on lowest day-rate. We compete on shipped outcomes inside environments that have to clear audit.

Senior-only delivery

Every engineer on every engagement is at least senior, typically eight to fifteen years deep in their craft. No bench rotations, no junior pyramid hidden behind a glossy proposal, no bait-and-switch after contract signature. The architect who scoped your engagement is the same person committing code by week three.

Audit-ready by default

FCA, PRA, EBA, BaFin, FINMA, HIPAA, SOC 2 Type II: every framework we work under is treated as a design constraint from day one, not a final-stage gate. Evidence trails, model-risk packs, change-control artefacts, and pen-test reports ship alongside the code, ready for second-line review without a remediation sprint.

Anti-drift delivery discipline

Small pods of three to seven engineers, each with a named delivery lead who owns scope, schedule, and outcomes from kickoff to hand-off, never a faceless team you have to chase for an answer. Weekly demos run against the signed scope, frequent verification gates catch regressions early, and quarterly outcome reviews measure real progress against the original business case rather than a moving target. Together those rituals catch scope drift before it has any chance to compound, so programmes that should take six months don't quietly stretch into eighteen, budgets stay anchored to what was agreed, and every milestone ships with a written, testable definition of done that both sides sign off before we move on.

Long-tail support beyond hand-off

We don't disappear the moment the engagement closes. Managed services, hypercare windows, named on-call rotations, or quarterly health checks: pick the depth that matches your operational risk profile. About seventy percent of clients return for a second programme, usually because the team that shipped the first one is still on the other end of the page.

Pharma client reviews

Words from the pharma teams we have shipped with.

Anonymous under MNDA. Each quote is from a senior pharma buyer who owned the engagement end to end.

First-Pass FDA Inspection

First clinical platform of mine that cleared an FDA Part 11 inspection on the first attempt. The validation pack and audit trail were ready before the inspector walked in.

VP Clinical OperationsTier-1 pharma, US
Pharma procurement questions

Things pharma buyers ask before signing the first SOW

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
Before you sign

Direct answers to what procurement, security, and delivery leads weigh before signing: compliance, integration, and the accountability we put in writing.

Are you 21 CFR Part 11 and EU Annex 11 compliant?

Yes. We engineer to 21 CFR Part 11 and EU Annex 11 from day one, electronic signatures, audit trails, access controls, and computer system validation are first-class deliverables, not retrofitted before the inspection. We ship the IQ/OQ/PQ pack alongside each release and sit with your QA team through validation review.